BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 31468958)

  • 1. 1H NMR-based lipidomics of rodent fur: species-specific lipid profiles and SCD1 inhibitor-related dermal toxicity.
    Khandelwal P; Stryker S; Chao H; Aranibar N; Lawrence RM; Madireddi M; Zhao W; Chen L; Reily MD
    J Lipid Res; 2014 Jul; 55(7):1366-74. PubMed ID: 24755647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Chemical Space of Kawakawa Leaf (
    Jayaprakash R; Ramzan F; Miles-Chan JL; Foster M; Mithen RF; Pook C
    Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Effects of Kawakawa (
    Ramzan F; Jayaprakash R; Pook C; Foster M; Miles-Chan JL; Mithen R
    Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress in the discovery and development of stearoyl CoA desaturase inhibitors.
    Uto Y
    Chem Phys Lipids; 2016 May; 197():3-12. PubMed ID: 26344107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stearoyl-CoA desaturase inhibitors: update on patented compounds.
    Liu G
    Expert Opin Ther Pat; 2009 Sep; 19(9):1169-91. PubMed ID: 19691439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Activation of Elemicin Leads to the Inhibition of Stearoyl-CoA Desaturase 1.
    Yang XN; Wang YK; Zhu X; Xiao XR; Dai MY; Zhang T; Qu Y; Yang XW; Qin HB; Gonzalez FJ; Li F
    Chem Res Toxicol; 2019 Oct; 32(10):1965-1976. PubMed ID: 31468958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Metabolic Activation in Elemicin-Induced Cellular Toxicity.
    Wang YK; Yang XN; Zhu X; Xiao XR; Yang XW; Qin HB; Gonzalez FJ; Li F
    J Agric Food Chem; 2019 Jul; 67(29):8243-8252. PubMed ID: 31271289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo antitumor activities of T-3764518, a novel and orally available small molecule stearoyl-CoA desaturase 1 inhibitor.
    Nishizawa S; Sumi H; Satoh Y; Yamamoto Y; Kitazawa S; Honda K; Araki H; Kakoi K; Imamura K; Sasaki M; Miyahisa I; Satomi Y; Nishigaki R; Hirayama M; Aoyama K; Maezaki H; Hara T
    Eur J Pharmacol; 2017 Jul; 807():21-31. PubMed ID: 28442322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
    Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
    Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: part 2. Pyridazine-based analogs.
    Yang SM; Tang Y; Rano T; Lu H; Kuo GH; Gaul MD; Li Y; Ho G; Lang W; Conway JG; Liang Y; Lenhard JM; Demarest KT; Murray WV
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1437-41. PubMed ID: 24405703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potent liver-selective stearoyl-CoA desaturase-1 (SCD1) inhibitors, thiazole-4-acetic acid derivatives, for the treatment of diabetes, hepatic steatosis, and obesity.
    Iida T; Ubukata M; Mitani I; Nakagawa Y; Maeda K; Imai H; Ogoshi Y; Hotta T; Sakata S; Sano R; Morinaga H; Negoro T; Oshida S; Tanaka M; Inaba T
    Eur J Med Chem; 2018 Oct; 158():832-852. PubMed ID: 30248655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic profiling of the anti-tumor drug regorafenib in mice.
    Wang YK; Xiao XR; Xu KP; Li F
    J Pharm Biomed Anal; 2018 Sep; 159():524-535. PubMed ID: 30055476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotoxic alkenylbenzene flavourings, a contribution to risk assessment.
    Martins C; Rueff J; Rodrigues AS
    Food Chem Toxicol; 2018 Aug; 118():861-879. PubMed ID: 29913232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochromes P450 1A2 and 3A4 Catalyze the Metabolic Activation of Sunitinib.
    Amaya GM; Durandis R; Bourgeois DS; Perkins JA; Abouda AA; Wines KJ; Mohamud M; Starks SA; Daniels RN; Jackson KD
    Chem Res Toxicol; 2018 Jul; 31(7):570-584. PubMed ID: 29847931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARα Mediates the Hepatoprotective Effects of Nutmeg.
    Yang XN; Liu XM; Fang JH; Zhu X; Yang XW; Xiao XR; Huang JF; Gonzalez FJ; Li F
    J Proteome Res; 2018 May; 17(5):1887-1897. PubMed ID: 29664296
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.